CI vs VRTX · P/E 2.4, rev $274.90B vs P/E 30, rev $12.00B
Cigna Corp (CI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CI currently screens at market cap $71.62B and trailing P/E 2.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CI and VRTX stock pages for the full models.
Not investment advice.